Rallybio reduces ATM offering cap from $100M to $9.55M under Sales Agreement with TD Cowen

Rallybio Corp

Amendment reduces aggregate offering price from $100,000,000 to $9,550,000.
As of March 13, 2025, no shares have been sold under the Sales Agreement.
TD Cowen receives up to 3.0% commission on gross proceeds in at-the-market sales.
Sales limited by public float rule: cannot exceed one-third of non-affiliate market value if public float <$75M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.